Large Cap Archives - Page 55 of 437

2 minute read

Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick

April 17, 2:39 PM

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300 cells/μL.

AMGN

2 minute read

Shell Defends Climate Goals, Rejects Shareholder Resolution As Damaging

By Lekha Gupta

April 17, 2:14 PM

Shell rejects shareholder resolution for tighter climate targets, stating it goes against good governance and could have negative impact on customers and energy security.

SHEL

2 minute read

Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What’s Driving Markets Wednesday?

By Piero Cingari

April 17, 2:09 PM

A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as investor confidence remains dampened by geopolitical and economic risks.

2 minute read

Several Google Employees Arrested In Protest Over $1.2B Israel Contract: Report

By Lekha Gupta

April 17, 2:00 PM

Several Google employees arrested for protesting $1.2 billion cloud contract with Israel. Protesters demanded withdrawal, facing disciplinary action.

GOOG

1 minute read

Chevron Pours $500M To Fund Renewable Energy Future: Report

By Lekha Gupta

April 17, 12:20 PM

Chevron's venture capital arm launches third fund for renewable energy, aiming to diversify and reduce emissions through innovation and investments.

CVX

2 minute read

Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years

By Vandana Singh

April 17, 11:48 AM

Sustained efficacy with Novartis' Kesimpta for up to 6 years in recently diagnosed relapsing multiple sclerosis. Significant reductions in relapses, MRI lesions, and disability worsening observed.

NVS

2 minute read

Sanofi’s Multiple Sclerosis Antibody Shows Reduction Of Disease Activity

By Vandana Singh

April 17, 11:37 AM

Discover results from Sanofi's Phase 2 study on frexalimab for relapsing multiple sclerosis. Explore sustained reduction in disease activity and lesion numbers with low relapse rates.

SNY

3 minute read

Real Estate Stocks Fall As Mortgage Rates Rise To 4-Month Highs: ‘Inflation Is Proving Tougher To Bring Down’

By Piero Cingari

April 17, 11:23 AM

Real estate stocks drop due to poor housing data and high mortgage rates, with concerns for sector's future. Rates highest since December 2023.

EGP

2 minute read

Why Prologis Shares Are Trading Lower Today

By Lekha Gupta

April 17, 9:26 AM

Prologis shares down after reporting Q1 results, with lower rental revenue and reduced FY24 guidance due to market conditions. CEO remains positive about long-term growth.

FPRO

2 minute read

Eli Lilly’s Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show

By Vandana Singh

April 17, 8:59 AM

Goundbreaking results in treating obstructive sleep apnea (OSA) with Eli Lilly's tirzepatide. See significant reductions in apnea-hypopnea index (AHI) and body weight, offering hope for OSA patients.

LLY